Real world effectiveness of PCSK-9 inhibitors combined with statins versus statins-based therapy among patients with very high risk of atherosclerotic cardiovascular disease in China (RWE-PCSK study)

BACKGROUND: The efficacy and safety of proprotein convertase subtilisin/kexin type 9 (PCSK-9) inhibitors were confirmed by several clinical trials, but its effectiveness in routine clinical practice in China has not been evaluated. This study aims to describe the real world effectiveness of PCSK-9 i...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Geriatr Cardiol
Autors principals: LIU, Yu-Qi, LI, Dan-Dan, CHAI, Meng, CONG, Hong-Liang, CONG, Xiao-Qiang, DAI, Jun, DU, Rong-Pin, GAO, Ming, GUO, Jin-Cheng, GUO, Yan-Qing, HONG, Xiao-Jian, HUANG, Rong-Chong, JIA, Feng-Shun, LI, Jia-Yu, LI, Qing, LIU, Jia-Mei, LIU, Xin-Ping, LIU, Yu-Guo, NIE, Hong-Gang, SHAO, Bing, SHEN, Xiao-Yu, SONG, Hai-Qing, SONG, Yi-Jun, WANG, Li-Jun, WANG, Shuo, WU, Dong-Mei, XIA, Jing, YANG, Zhi-Yong, YU, Hong-Ying, ZHANG, Hui, ZHANG, Tie-Mei, ZHAO, Ji-Yi, ZHAO, Liang-Chen, ZHENG, Ming-Qi, CHEN, Yun-Dai
Format: Artigo
Idioma:Inglês
Publicat: Science Press 2021
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8100428/
https://ncbi.nlm.nih.gov/pubmed/33995505
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.11909/j.issn.1671-5411.2021.04.005
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars